BBA
AZN icon

Baader Bank Aktiengesellschaft’s AstraZeneca AZN Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$884K Hold
4,699
– – 0.07% 200
2026
Q1 		$920K Buy
+4,699
New +$906K 0.07% 180
2024
Q3 		– Sell
-2,397
Closed -$370K – 453
2024
Q2 		$370K Buy
+2,397
New +$361K 0.02% 287

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baader Bank Aktiengesellschaft's AZN Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft held its AstraZeneca (AZN) position steady in Q2 2026 at 4,699 shares worth $884K. The position accounts for 0.07% of the portfolio, ranked #200.

Baader Bank Aktiengesellschaft first reported a position in AZN in Q2 2024 and has held it in 3 quarters since. The position peaked at $920K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 4,699 shares of AstraZeneca worth $884K as of Q2 2026.
  • Baader Bank Aktiengesellschaft left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.07% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #200 holding.
  • Baader Bank Aktiengesellschaft first reported a position in AstraZeneca in Q2 2024 and has held it in 3 quarters since.
  • Baader Bank Aktiengesellschaft's AstraZeneca position peaked at $920K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.